Edition:
United Kingdom

Kuros Biosciences H1 Net Loss At CHF 5.2 Million


Tuesday, 20 Aug 2019 

Aug 20 (Reuters) - Kuros Biosciences AG ::PRODUCT SALES WERE CHF 0.9 MILLION IN FIRST HALF OF 2019, A SUBSTANTIAL INCREASE COMPARED TO H1 2018.OTHER INCOME IN FIRST HALF OF 2019 AND 2018 WAS CHF 0.2 MILLION AND CHF 1.1 MILLION RESPECTIVELY.NET LOSS AS PER JUNE 30, 2019 AMOUNTS TO CHF 5.2 MILLION AND REMAINS UNCHANGED COMPARED TO CORRESPONDING PERIOD IN FIRST HALF OF 2018..EXPECTS A FURTHER ACCELERATION FOR REMAINDER OF 2019..